SynNotch-CAR T Cells Overcome Challenges of Specificity, Heterogeneity, and Persistence in Treating Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
SynNotch-CAR T Cells Overcome Challenges of Specificity, Heterogeneity, and Persistence in Treating Glioblastoma
Sci Transl Med 2021 Apr 28;13(591)eabe7378, JH Choe, PB Watchmaker, MS Simic, RD Gilbert, AW Li, NA Krasnow, KM Downey, W Yu, DA Carrera, A Celli, J Cho, JD Briones, JM Duecker, YE Goretsky, R Dannenfelser, L Cardarelli, O Troyanskaya, SS Sidhu, KT Roybal, H Okada, WA LimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.